Literature DB >> 6781419

Plasma fibronectin is a component of cryoglobulins from patients with connective tissue and other diseases.

B Anderson, M Rucker, R Entwistle, F R Schmid, G W Wood.   

Abstract

Twenty-four washed cryoglobulin precipitates were examined for the presence of plasma fibronectin, immunoglobulins, complement components Clq and C3, and fibrinogen. Plasma fibronectin was detected in all preparations by immunodiffusion with antifibronectin serum, whereas the other components were found in some but not all of the cryoglobulins.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6781419      PMCID: PMC1000655          DOI: 10.1136/ard.40.1.50

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  16 in total

1.  Binding of soluble form of fibroblast surface protein, fibronectin, to collagen.

Authors:  E Engvall; E Ruoslahti
Journal:  Int J Cancer       Date:  1977-07-15       Impact factor: 7.396

2.  Identification of antinative DNA antibodies in cryoglobulinemic states.

Authors:  J L Roberts; E J Lewis
Journal:  Am J Med       Date:  1978-09       Impact factor: 4.965

3.  Cryoglobulinemia and disease.

Authors:  E V Barnett; R Bluestone; A Cracchiolo; L S Goldberg; G L Kantor; R M McIntosh
Journal:  Ann Intern Med       Date:  1970-07       Impact factor: 25.391

Review 4.  Cryoimmunoglobulins.

Authors:  H M Grey; P F Kohler
Journal:  Semin Hematol       Date:  1973-04       Impact factor: 3.851

5.  Cryoglobulinemia--a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity.

Authors:  M Meltzer; E C Franklin; K Elias; R T McCluskey; N Cooper
Journal:  Am J Med       Date:  1966-06       Impact factor: 4.965

6.  Cryoglobulinemia--a study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability.

Authors:  M Meltzer; E C Franklin
Journal:  Am J Med       Date:  1966-06       Impact factor: 4.965

7.  Biologic and clinical significance of cryoglobulins. A report of 86 cases.

Authors:  J C Brouet; J P Clauvel; F Danon; M Klein; M Seligmann
Journal:  Am J Med       Date:  1974-11       Impact factor: 4.965

8.  Interaction of fibronectin with antibodies and collagen in radioimmunoassay.

Authors:  E Ruoslahti; M Vuento; E Engvall
Journal:  Biochim Biophys Acta       Date:  1978-06-21

9.  Interactions among heparin, cold-insoluble globulin, and fibrinogen in formation of the heparin-precipitable fraction of plasma.

Authors:  N E Stathakis; M W Mosesson
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

10.  Determination of cryoglobulins as lipoprotein-autoantibody immune complexes and antigenic determinants against antilipoprotein autoantibody.

Authors:  H Kodama
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

View more
  6 in total

1.  Affinity of fibronectin for polyclonal IgG.

Authors:  M Salvarrey; A Rostagno
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

2.  Fibronectin in polyethylene glycol precipitates: evidence for a role in immune complexes.

Authors:  J S Coppock; D L Scott; S D Carter; T M Moreland; M W Robinson
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

3.  Fibronectin in chronic inflammation: studies using the rat air pouch model of chronic allergic inflammation.

Authors:  D L Scott; M W Robinson; S Yoshino
Journal:  Br J Exp Pathol       Date:  1985-10

4.  Diagnostic relevance of fibronectin in cryoprecipitates.

Authors:  M W Robinson; K W Walton; D G Scott; D L Scott
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

5.  Fibronectin and immune complexes in rheumatic diseases.

Authors:  K E Herbert; J S Coppock; A M Griffiths; A Williams; M W Robinson; D L Scott
Journal:  Ann Rheum Dis       Date:  1987-10       Impact factor: 19.103

6.  Human anti-fibronectin antibodies in systemic lupus erythematosus: occurrence and antigenic specificity.

Authors:  M S Atta; R J Powell; N D Hopkinson; I Todd
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.